Pleomorphic adenoma

Jump to navigation Jump to search

WikiDoc Resources for Pleomorphic adenoma

Articles

Most recent articles on Pleomorphic adenoma

Most cited articles on Pleomorphic adenoma

Review articles on Pleomorphic adenoma

Articles on Pleomorphic adenoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pleomorphic adenoma

Images of Pleomorphic adenoma

Photos of Pleomorphic adenoma

Podcasts & MP3s on Pleomorphic adenoma

Videos on Pleomorphic adenoma

Evidence Based Medicine

Cochrane Collaboration on Pleomorphic adenoma

Bandolier on Pleomorphic adenoma

TRIP on Pleomorphic adenoma

Clinical Trials

Ongoing Trials on Pleomorphic adenoma at Clinical Trials.gov

Trial results on Pleomorphic adenoma

Clinical Trials on Pleomorphic adenoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pleomorphic adenoma

NICE Guidance on Pleomorphic adenoma

NHS PRODIGY Guidance

FDA on Pleomorphic adenoma

CDC on Pleomorphic adenoma

Books

Books on Pleomorphic adenoma

News

Pleomorphic adenoma in the news

Be alerted to news on Pleomorphic adenoma

News trends on Pleomorphic adenoma

Commentary

Blogs on Pleomorphic adenoma

Definitions

Definitions of Pleomorphic adenoma

Patient Resources / Community

Patient resources on Pleomorphic adenoma

Discussion groups on Pleomorphic adenoma

Patient Handouts on Pleomorphic adenoma

Directions to Hospitals Treating Pleomorphic adenoma

Risk calculators and risk factors for Pleomorphic adenoma

Healthcare Provider Resources

Symptoms of Pleomorphic adenoma

Causes & Risk Factors for Pleomorphic adenoma

Diagnostic studies for Pleomorphic adenoma

Treatment of Pleomorphic adenoma

Continuing Medical Education (CME)

CME Programs on Pleomorphic adenoma

International

Pleomorphic adenoma en Espanol

Pleomorphic adenoma en Francais

Business

Pleomorphic adenoma in the Marketplace

Patents on Pleomorphic adenoma

Experimental / Informatics

List of terms related to Pleomorphic adenoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Synonyms and keywords: Pleomorphic adenoma of the salivary glands; BMT; Benign mixed tumors of the salivary gland

Overview

Pleomorphic adenoma (also known as "Benign mixed tumor of the salivary gland") is a benign neoplastic tumor of the salivary glands. Pleomorphic adenoma is the most common type of salivary gland tumor and the most common tumor of the parotid gland.[1]

Historical Perspective

  • Pleomorphic adenoma was first discovered by Beahrs in in 1957.

Classification

  • Pleomorphic adenoma may be classified according to anatomical distribution into 4 groups:
  • Parotid gland pleomorphic adenoma
  • Superficial lobe pleomorphic adenoma (most common)
  • Submandibular gland pleomorphic adenoma
  • Minor salivary gland pleomorphic adenoma
  • Sublingual gland pleomorphic adenoma
  • Pleomorphic adenoma may also be classified

Three histological types have been described:

  • Mixed (hypocellular)(most common)
  • Cellular
  • Classic
  • Other variants of pleomorphic adenoma, include: lacrimal gland pleomorphic adenoma, where they account for approximately 50% of lacrimal gland tumors.

Pathophysiology

  • The pathogenesis of pleomorphic adenoma is characterized by an admixture of polygonal epithelial and spindle-shaped myoepithelial elements.
  • Pleomorphic adenoma is commonly located in the parotid gland (80%)
  • The mutation on PLAG1 gene has been associated with the development of pleomorphic adenoma.
  • On gross pathology, characteristic findings of pleomorphic adenoma, include:
  • May have cartilaginous appearance
  • Typically well-circumscribed
  • On microscopic histopathological analysis, characteristic findings of pleomorphic adenoma, include:
  • Mixture of epithelial and myoepithelial elements
  • Background stroma that may be mucoid, mixed, cartilaginous or hyaline
  • Epithelial elements may be arranged in duct-like structures, sheets, clumps and/or interlacing strands and consist of polygonal, spindle or stellate-shaped cells (hence pleomorphism)
  • Tumor is usually enveloped by a fibrous capsule
  • On inmunohistochemistry, characteristic findings of pleomorphic adenoma, include:
  • Positive S-100
  • Positive SMA
  • Positive GFAP

Causes

  • Common causes of pleomorphic adenoma, include:

Differentiating Pleomorphic Adenoma from Other Diseases

  • Pleomorphic adenoma must be differentiated from other diseases that cause dry-mouth, single-nodular parotid mass, and dysphagia, such as:
  • Warthin tumour
  • Mucoepidermoid carcinoma
  • Myoepithelioma
  • Adenoid cystic carcinoma

Epidemiology and Demographics

  • Pleomorphic adenoma is common
  • Pleomorphic adenoma accounts for 60% of all parotid gland tumors, and it represents 45-75% of all salivary gland neoplasms.
  • The incidence of pleomorphic adenoma is approximately 2-3.5 per 100,000 individuals worldwide.

Age

  • Pleomorphic adenoma is more commonly observed among patients aged [age range] years old.
  • Pleomorphic adenoma is more commonly observed among [elderly patients/young patients/children].

Gender

  • [Gender 1] are more commonly affected with pleomorphic adenoma than [gender 2].
  • The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race

  • There is no racial predilection for pleomorphic adenoma.

Risk Factors

  • Common risk factors in the development of pleomorphic adenoma, include:

Natural History, Complications and Prognosis

  • The majority of patients with pleomorphic adenoma remain asymptomatic for years.
  • Early clinical features include dry mouth, difficulty swallowing, and a palpable single nodular mass.
  • If left untreated, patients with pleomorphic adenoma may progress to develop malignant transformation.
  • Common complications of pleomorphic adenoma, include:
  • If there is a malignant transformation, prognosis is generally poor, and the 5- year survival rate of patients with pleomorphic adenoma is approximately 30%.

Diagnosis

Symptoms

  • Pleomorphic adenoma may be initially asymptomatic.
  • Symptoms of pleomorphic adenoma may include the following:
  • Dry mouth
  • Dysphagia
  • Painful chewing

Physical Examination

  • Patients with pleomorphic adenoma usually are well-appearing.
  • Physical examination may be remarkable for:
  • Single, mobile, and painless nodular mass.
  • Eversion of the ear lobe
  • [finding 3]
  • [finding 4]


Laboratory Findings

  • There are no specific laboratory findings associated with pleomorphic adenoma.

Imaging Findings

  • MRI is the imaging modality of choice for pleomorphic adenoma.
  • On CT, characteristic findings of pleomorphic adenoma, include:
  • Smooth, and well-marginated tumors
  • The attenuation values of the mass are usually homogeneous and higher than that of the surrounding gland
  • Tumor enhancement is variable and can result in a missed diagnosis if delayed images are not acquired
  • Pleomorphic adenomas are poorly enhancing in the early phase of contrast enhancement, though the amount of enhancement increases over time).
  • On MRI, characteristic findings of pleomorphic adenoma, include:
  • Pleomorphic adenomas are usually well-circumscribed
  • Homogeneous masses with low intensity on T1-weighted images and high intensity on T2-weighted images.
  • They commonly have a rim of decreased signal intensity on T2-weighted images.
  • After gadolinium enhancement, the tumors are homogeneously enhancing unless they are large.

Gallery

Other Diagnostic Studies

Treatment

Medical Therapy

  • There is no treatment for pleomorphic adenoma; the mainstay of therapy is surgery.
  • In some cases, patients with pleomorphic adenoma can receive medications to stimulate saliva production, such as:
  • Pilocarpine
  • Cevimeline

Surgery

  • Surgery is the mainstay of therapy for pleomorphic adenoma.
  • Surgical excision in conjunction with pre-surgical biopsy is the most common approach to the treatment of pleomorphic adenoma.
  • The recurrence rate after surgery will depend on the histological subtype. Mixed pleomorphic adenomas have a higher recurrence rate.

Prevention

  • There are no primary preventive measures available for pleomorphic adenoma.
  • Once diagnosed and successfully treated, patients with pleomorphic adenoma are followed-up every 6 or 12 months.

References

  1. Ewa J. Bialek, Wieslaw Jakubowski, Piotr Zajkowski, Kazimierz T. Szopinski, and Antoni Osmolski. US of the Major Salivary Glands: Anatomy and Spatial Relationships, Pathologic Conditions, and Pitfalls. RadioGraphics 2006 26: 745-763.